Literature DB >> 18024907

The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons.

Rennos Fragkoudis1, Lucy Breakwell, Clive McKimmie, Amanda Boyd, Gerald Barry, Alain Kohl, Andres Merits, John K Fazakerley.   

Abstract

Semliki Forest virus (SFV) infection of the mouse provides a powerful model to study the pathogenesis of virus encephalitis. SFV and other alphavirus-based vector systems are increasingly used in biotechnology and medicine. This study analysed the strong susceptibility of this virus to type I interferon (IFN) responses. Following intraperitoneal infection of adult mice, SFV strain A7(74) was efficiently (100 %) neuroinvasive. In contrast, SFV4 was poorly (21 %) neuroinvasive. Upon entry into the brain, both viruses activated type I IFN responses. As determined by quantitative RT-PCR, activation of the IFN-alpha gene was proportional to virus RNA load. An intact type I IFN system was required for protection against both strains of SFV. IFN strongly curtailed virus spread in many cell types and in many tissues. In mice with an intact type I IFN system, infected cells were rarely observed and tissue tropism was difficult to determine. In the absence of a functional type I IFN system, the tropism and the potential for rapid and widespread infection of this virus was revealed. Virus infection was readily observed in the myocardium, endocardium, exocrine pancreas, adipose tissue, smooth muscle cells and in the brain in meningeal cells, ependymal cells and oligodendrocytes. In the brains of mice with and without type I IFN responses, virus infection of neurons remained rare and focal, indicating that the previously described restricted replication of SFV A7(74) in neurons is not mediated by type I IFN responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18024907     DOI: 10.1099/vir.0.83191-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  29 in total

1.  Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.

Authors:  Christina L Gardner; Crystal W Burke; Stephen T Higgs; William B Klimstra; Kate D Ryman
Journal:  Virology       Date:  2012-02-01       Impact factor: 3.616

2.  Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection.

Authors:  Kalen R Dionne; John M Galvin; Stephanie A Schittone; Penny Clarke; Kenneth L Tyler
Journal:  J Neurovirol       Date:  2011-06-14       Impact factor: 2.643

3.  Interferon-β sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models.

Authors:  Janne Ruotsalainen; Miika Martikainen; Minna Niittykoski; Tuulia Huhtala; Tytti Aaltonen; Jari Heikkilä; John Bell; Markus Vähä-Koskela; Ari Hinkkanen
Journal:  Mol Ther       Date:  2012-03-20       Impact factor: 11.454

4.  Encapsidation of host-derived factors correlates with enhanced infectivity of Sindbis virus.

Authors:  Kevin J Sokoloski; Anthony J Snyder; Natalia H Liu; Chelsea A Hayes; Suchetana Mukhopadhyay; Richard W Hardy
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

5.  IFN-gamma-mediated suppression of coronavirus replication in glial-committed progenitor cells.

Authors:  Lucia Whitman; Haixia Zhou; Stanley Perlman; Thomas E Lane
Journal:  Virology       Date:  2008-12-06       Impact factor: 3.616

6.  PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response.

Authors:  Gerald Barry; Lucy Breakwell; Rennos Fragkoudis; Ghassem Attarzadeh-Yazdi; Julio Rodriguez-Andres; Alain Kohl; John K Fazakerley
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

7.  Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses.

Authors:  Crystal W Burke; Christina L Gardner; Joshua J Steffan; Kate D Ryman; William B Klimstra
Journal:  Virology       Date:  2009-09-25       Impact factor: 3.616

8.  Myd88-dependent toll-like receptor 7 signaling mediates protection from severe Ross River virus-induced disease in mice.

Authors:  Lauren M Neighbours; Kristin Long; Alan C Whitmore; Mark T Heise
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

9.  Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice.

Authors:  Jari E Heikkilä; Markus J V Vähä-Koskela; Janne J Ruotsalainen; Miika W Martikainen; Marianne M Stanford; J Andrea McCart; John C Bell; Ari E Hinkkanen
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

10.  Type I interferon receptor-independent and -dependent host transcriptional responses to mouse hepatitis coronavirus infection in vivo.

Authors:  Matthijs Raaben; Marian J A Groot Koerkamp; Peter J M Rottier; Cornelis A M de Haan
Journal:  BMC Genomics       Date:  2009-08-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.